In last trading session, Aethlon Medical Inc (NASDAQ:AEMD) saw 0.39 million shares changing hands with its beta currently measuring 1.77. Company’s recent per share price level of $0.58 trading at -$0.03 or -4.25% at ring of the bell on the day assigns it a market valuation of $8.44M. That closing price of AEMD’s stock is at a discount of -218.97% from its 52-week high price of $1.85 and is indicating a premium of 58.62% from its 52-week low price of $0.24.
For Aethlon Medical Inc (AEMD), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.00. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.14 in the current quarter.
Aethlon Medical Inc (NASDAQ:AEMD) trade information
Upright in the red during last session for losing -4.25%, in the last five days AEMD remained trading in the red while hitting it’s week-highest on Tuesday, 02/18/25 when the stock touched $0.58 price level, adding 12.9% to its value on the day. Aethlon Medical Inc’s shares saw a change of -32.16% in year-to-date performance and have moved -7.57% in past 5-day. Aethlon Medical Inc (NASDAQ:AEMD) showed a performance of -5.42% in past 30-days.
Aethlon Medical Inc (AEMD) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 37.58% during past 5 years.
On the other hand, Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 72.79 shares of worth $42465.0 or 0.50% of the total outstanding shares. The later fund manager was in possession of 21.22 shares on Sep 30, 2024 , making its stake of worth around $12382.0 in the company or a holder of 0.15% of company’s stock.
